Proteros

Proteros Biostructures GmbH is a leader in drug discovery, known for their scientific expertise and innovative solutions. Among their many services, fragment-based drug discovery (FBDD) stands out as particularly impactful. This technique involves screening small chemical fragments that bind to target proteins, forming the basis for developing potent drugs. Proteros’s proficiency in FBDD provides detailed insights into fragment-protein interactions, streamlining the drug discovery process. Their commitment to advancing scientific understanding and their global client base highlight their role as a key player in the pharmaceutical industry. Proteros’s headquarters in Munich facilitate their extensive international reach, serving clients worldwide. Address: Proteros USA Inc., One Broadway, 14th Floor, Cambridge, MA, 02142